Skip to main content
EJNMMI Research
Fig. 7 | EJNMMI Research

Fig. 7

From: Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA0,Tyr3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach

Fig. 7

Evaluation of hybrid-protocol-based TAC parameters in comparison to the reference protocol for both therapies; the ratio of the reference-protocol-based and SPECT-based effective half-lives (T1/2,RP/T1/2,HP) and the ratio of the y-axis intercepts for the reference-protocol-based and the hybrid-protocol-based TACs (A0,RP/A0,HP) are provided; the black curve indicates the optimal case, for which the area under both TACs (AUC) is equal

Back to article page